BA
EXAS

Bridgewater Associates’s Exact Sciences EXAS Stock Holding History

Bridgewater Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,611
Closed -$387K – 898
2024
Q1 		$387K Sell
5,611
-2,720
-33% -$172K ﹤0.01% 642
2023
Q4 		$616K Buy
8,331
+87
+1% +$5.7K ﹤0.01% 687
2023
Q3 		$562K Buy
8,244
+1,030
+14% +$87.4K ﹤0.01% 679
2023
Q2 		$677K Buy
7,214
+1,153
+19% +$89.9K ﹤0.01% 627
2023
Q1 		$411K Buy
6,061
+1,777
+41% +$114K ﹤0.01% 662
2022
Q4 		$212K Buy
+4,284
New +$175K ﹤0.01% 804
2022
Q2 		– Sell
-9,647
Closed -$675K – 1020
2022
Q1 		$675K Buy
+9,647
New +$705K ﹤0.01% 856
2021
Q4 		– Sell
-3,065
Closed -$293K – 763
2021
Q3 		$293K Buy
+3,065
New +$324K ﹤0.01% 637

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bridgewater Associates's EXAS Position: Q2 2024 in Review

Bridgewater Associates sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 5,611 shares — an estimated $387K sold.

Bridgewater Associates first reported a position in EXAS in Q3 2021 and held it in 8 quarters. The position peaked at $677K in Q2 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Bridgewater Associates reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Bridgewater Associates sold 5,611 Exact Sciences shares in Q2 2024, an estimated $387K.
  • Bridgewater Associates first reported a position in Exact Sciences in Q3 2021 and held it in 8 quarters.
  • Bridgewater Associates's Exact Sciences position peaked at $677K in Q2 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Bridgewater Associates's 13F filing for Q2 2024, filed 14 Aug 2024.